Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022

BACKGROUND: The reported rate of cardiovascular adverse events (CAE) caused by immune checkpoint inhibitors (ICI) is low but potentially fatal. Assess the risk of CAE in cancer patients and compare the incidence of CAE between Chinese developed ICIs and imported ICIs. METHODS: A retrospective analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Si, Bai, Hansheng, Zhang, Ling, He, Jiamin, Luo, Xiangru, Wang, Shiyi, Fan, Guangjun, Sun, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399397/
https://www.ncbi.nlm.nih.gov/pubmed/36035942
http://dx.doi.org/10.3389/fcvm.2022.969942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399397/
https://www.ncbi.nlm.nih.gov/pubmed/36035942
http://dx.doi.org/10.3389/fcvm.2022.969942

Ejemplares similares